Anti-diabetic effects of vanadium(III, IV, V)-chlorodipicolinate complexes in streptozotocin-induced diabetic rats

BioMetals

Volumn 22, Issue 6, 2009, Pages 895-905

  Li, Ming ^a   Ding, Wenjun ^a   Smee, Jason J ^b,c   Baruah, Bharat ^b   Willsky, Gail R ^d   Crans, Debbie C ^b  

^a UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^b Department of Ecosystem Science and Sustainability   (United States)

^c UNIVERSITY OF TEXAS AT TYLER   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

Author keywords

Chlorodipicolinate; Diabetes; Insulin enhancing; Lipid; Redox; Vanadium

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; GLUCOSE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VANADIUM CHLORODIPICOLINATE; VANADIUM DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD GLUCOSE MONITORING; CHOLESTEROL BLOOD LEVEL; COMPLEX FORMATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; KIDNEY FUNCTION; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; RAT; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

ADMINISTRATION, ORAL; ALKALINE PHOSPHATASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BLOOD GLUCOSE; BLOOD UREA NITROGEN; CHLORINE; CHOLESTEROL; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; HYPOGLYCEMIC AGENTS; INSULIN; KIDNEY FUNCTION TESTS; OXIDATION-REDUCTION; PICOLINIC ACIDS; RATS; RATS, WISTAR; STREPTOZOCIN; TRIGLYCERIDES; VANADATES; VANADIUM;

ANIMALIA; RATTUS;

EID: 71349083092     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10534-009-9241-4     Document Type: Article

References (42)

1. SS Amin K Cryer B Zhang SK Dutta SS Eaton OP Anderson SM Miller BA Reul SM Brichard DC Crans 2000 Chemistry and insulin-mimetic properties of bis(acetylacetonate)oxovanadium(IV) and derivatives Inorg Chem 39 406 416 10.1021/ic9905897 10.1021/ic9905897 1:CAS:528:DC%2BD3cXhs1Cqtw%3D%3D 11229556
2. PE Arkkila PJ Koskinen IM Kantola T Ronnemaa E Seppanen JS Viikari 2001 Diabetic complications are associated with liver enzyme activities in people with type 1 diabetes Diabetes Res Clin Pract 52 113 118 10.1016/S0168-8227(00) 00241-2 10.1016/S0168-8227(00)00241-2 1:CAS:528:DC%2BD3MXislGlu7c%3D 11311965 (Pubitemid 32335604)
3. RA Bennett AE Pegg 1981 Alkylation of DNA in rat tissues following administration of streptozotocin Cancer Res 41 2786 2790 1:CAS:528: DyaL3MXkslegs7o%3D 6454479
4. G Biesenbach 1989 Disorders of lipid metabolism in diabetes mellitus Wien Med Wochenschr Suppl 105 9 17 1:STN:280:DyaK3c7kt1yltg%3D%3D 2694631
5. P Buglyo DC Crans EM Nagy RL Lindo L Yang JJ Smee W Jin LH Chi ME Godzala Iii GR Willsky 2005 Aqueous chemistry of the vanadium(III) (V(III)) and the V(III)-dipicolinate systems and a comparison of the effect of three oxidation states of vanadium compounds on diabetic hyperglycemia in rats Inorg Chem 44 5416 5427 10.1021/ic048331q 10.1021/ic048331q 1:CAS:528:DC%2BD2MXltlGgtbY%3D 16022540 (Pubitemid 41096417)
6. Chatterjee M, Maji M, Ghosh S, Mak TCW (1998) Studies of V(III) complexes with selected N-heterocyclic carboxylato NO donor ligands: structure of a new seven-coordinated pentagonal bipyramidal complex containing picolinato ligands. J Chem Soc Dalton Trans 3641-3646. doi: 10.1039/a804160a
7. N Cohen M Halberstam P Shlimovich CJ Chang H Shamoon L Rossetti 1995 Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus J Clin Invest 95 2501 2509 10.1172/JCI117951 10.1172/JCI117951 1:CAS:528:DyaK2MXmtV2qsr0%3D 7769096
8. DC Crans 2000 Chemistry and insulin-like properties of vanadium(IV) and vanadium(V) compounds J Inorg Biochem 80 123 131 10.1016/S0162-0134(00)00048-9 10.1016/S0162-0134(00)00048-9 1:CAS:528:DC%2BD3cXkvVOrurg%3D 10885472 (Pubitemid 30628773)
9. DC Crans L Yang T Jakusch T Kiss 2000 Aqueous chemistry of ammonium (Dipicolinato)oxovanadate(V): the first organic vanadium(V) insulin-mimetic compound Inorg Chem 39 4409 4416 10.1021/ic9908367 10.1021/ic9908367 1:CAS:528:DC%2BD3cXmt1Kitrk%3D
10. DC Crans M Mahroof-Tahir MD Johnson PC Wilkins L Yang K Robbins A Johnson JA Alfano ME Godzala, et al. 2003 Vanadium(IV) and vanadium(V) complexes of dipicolinic acid and derivatives. Synthesis, X-ray structure, solution state properties and effects in rats with STZ-induced diabetes Inorg Chim Acta 356 365 378 10.1016/S0020-1693(03)00430-4 10.1016/S0020-1693(03)00430-4 1:CAS:528:DC%2BD3sXpt1Ghtbw%3D
11. DC Crans JJ Smee E Gaidamauskas L Yang 2004 The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds Chem Rev 104 849 902 10.1021/cr020607t 10.1021/cr020607t 1:CAS:528:DC%2BD2cXnvFWisw%3D%3D 14871144
12. K Cusi S Cukier RA DeFronzo M Torres FM Puchulu JCP Redondo 2001 Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes J Clin Endocrinol Metab 86 1410 1417 10.1210/jc.86.3.1410 10.1210/jc.86.3.1410 1:CAS:528:DC%2BD3MXitFWnurg%3D 11238540 (Pubitemid 32323036)
13. AB Goldfine M-E Patti L Zuberi BJ Goldstein R LeBlanc EJ Landaker ZY Jiang GR Willsky CR Kahn 2000 Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies Metabolism 49 400 410 10.1016/S0026-0495(00)90418-9 10.1016/S0026-0495(00)90418- 9 1:CAS:528:DC%2BD3cXhvVeqtLg%3D 10726921
14. H Gylling JA Tuominen VA Koivisto TA Miettinen 2004 Cholesterol metabolism in type 1 diabetes Diabetes 53 2217 2222 10.2337/diabetes.53.9.2217 10.2337/diabetes.53.9.2217 1:CAS:528:DC%2BD2cXns1Shsr4%3D 15331530 (Pubitemid 39145574)
15. M Haratake M Fukunaga M Ono M Nakayama 2005 Synthesis of vanadium(IV, V) hydroxamic acid complexes and in vivo assessment of their insulin-like activity J Biol Inorg Chem 10 250 258 10.1007/s00775-005-0634-8 10.1007/s00775-005-0634-8 1:CAS:528:DC%2BD2MXktVOqsr0%3D 15806386 (Pubitemid 40768089)
16. CE Heyliger AG Tahiliani JH McNeill 1985 Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats Science 227 1474 1477 10.1126/science.3156405 10.1126/science.3156405 1:CAS:528: DyaL2MXhs1Ckur8%3D 3156405
17. K Kawabe Y Yoshikawa Y Adachi H Sakurai 2006 Possible mode of action for insulinomimetic activity of vanadyl(IV) compounds in adipocytes Life Sci 78 2860 2866 10.1016/j.lfs.2005.11.008 10.1016/j.lfs.2005.11.008 1:CAS:528: DC%2BD28XjvValsbc%3D 16337244
18. M Koyuturk S Tunali S Bolkent R Yanardag 2005 Effects of vanadyl sulfate on liver of streptozotocin-induced diabetic rats Biol Trace Elem Res 104 233 247 10.1385/BTER:104:3:233 10.1385/BTER:104:3:233 1:CAS:528:DC%2BD2MXmtFKrtr4%3D 15930593 (Pubitemid 40825582)
19. M Li JJ Smee W Ding DC Crans 2009 Anti-diabetic effects of sodium 4-amino-2,6-dipicolinatodioxovanadium(V) dihydrate in streptozotocin-induced diabetic rats J Inorg Biochem 103 585 10.1016/j.jinorgbio.2008.11.011 10.1016/j.jinorgbio.2008.11.011 1:CAS:528:DC%2BD1MXjsFans7s%3D 19203797
20. MW Makinen MJ Brady 2002 Structural origins of the insulin-mimetic activity of bis(acetylacetonato)oxovanadium(IV) J Biol Chem 277 12215 12220 10.1074/jbc.M110798200 10.1074/jbc.M110798200 1:CAS:528:DC%2BD38XivVektb0%3D 11815612 (Pubitemid 34952788)
21. L Marzban R Rahimian RW Brownsey JH McNeill 2002 Mechanisms by which bis(maltolato)oxovanadium(IV) normalizes phosphoenolpyruvate carboxykinase and glucose-6-phosphatase expression in streptozotocin-diabetic rats in vivo Endocrinology 143 4636 10.1210/en.2002-220732 10.1210/en.2002-220732 1:CAS:528:DC%2BD38Xpt1eltrg%3D 12446591 (Pubitemid 35397605)
22. JH McNeill VG Yuen S Dai C Orvig 1995 Increased potency of vanadium using organic ligands Mol Cell Biochem 153 175 180 10.1007/BF01075935 10.1007/BF01075935 1:CAS:528:DyaK28Xis1yntQ%3D%3D 8927036 (Pubitemid 26003382)
23. MZ Mehdi SK Pandey JF Theberge AK Srivastava 2006 Insulin signal mimicry as a mechanism for the insulin-like effects of vanadium Cell Biochem Biophys 44 73 81 10.1385/CBB:44:1:073 10.1385/CBB:44:1:073 1:CAS:528:DC%2BD28Xht12ltLs%3D 16456236
24. M Melchior SJ Rettig BD Liboiron KH Thompson VG Yuen JH McNeill C Orvig 2001 Insulin-enhancing vanadium(III) complexes Inorg Chem 40 4686 4690 10.1021/ic000984t 10.1021/ic000984t 1:CAS:528:DC%2BD3MXltlCmu7g%3D 11511216 (Pubitemid 32911068)
25. M Nannipieri C Gonzales S Baldi R Posadas K Williams SM Haffner MP Stern E Ferrannini 2005 Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study Diabetes Care 28 1757 1762 10.2337/diacare.28.7. 1757 10.2337/diacare.28.7.1757 1:CAS:528:DC%2BD2MXms12nurw%3D 15983331 (Pubitemid 40923089)
26. KJ Ooms SE Bolte JJ Smee B Baruah DC Crans T Polenova 2007 Investigating the vanadium environments in hydroxylamido V(V) dipicolinate complexes using 51V NMR spectroscopy and density functional theory Inorg Chem 46 9285 9293 10.1021/ic7012667 10.1021/ic7012667 1:CAS:528:DC%2BD2sXhtV2msL%2FM 17902653
27. S Ramanadham JJ Mongold RW Brownsey GH Cros JH McNeill 1989 Oral vanadyl sulfate in treatment of diabetes mellitus in rats Am J Physiol 257 H904 H911 1:CAS:528:DyaL1MXls1Oisb4%3D 2675634
28. D Rehder J Costa Pessoa CF Geraldes MC Castro T Kabanos T Kiss B Meier G Micera L Pettersson, et al. 2002 In vitro study of the insulin-mimetic behaviour of vanadium(IV, V) coordination compounds J Biol Inorg Chem 7 384 396 10.1007/s00775-001-0311-5 10.1007/s00775-001-0311-5 1:CAS:528: DC%2BD38Xjt1entbk%3D 11941496 (Pubitemid 36061690)
29. BA Reul SS Amin JP Buchet LN Ongemba DC Crans SM Brichard 1999 Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats Br J Pharmacol 126 467 477 10.1038/sj.bjp.0702311 10.1038/sj.bjp.0702311 1:CAS:528:DyaK1MXht1ersL8%3D 10077240 (Pubitemid 29057598)
30. H Sakurai K Fujii H Watanabe H Tamura 1995 Orally active and long-term acting insulin-mimetic vanadyl complex: bis(Picolinato)oxovanadium(IV) Biochem Biophys Res Commun 214 1095 1101 10.1006/bbrc.1995.2398 10.1006/bbrc.1995.2398 1:CAS:528:DyaK2MXot1yht7s%3D 7575515
31. 2) coordination mode; in vitro and in vivo evaluations in rats J Inorg Biochem 80 99 105 10.1016/S0162-0134(00)00045-3 10.1016/S0162-0134(00)00045-3 1:CAS:528:DC%2BD3cXkvVOrur0%3D 10885469 (Pubitemid 30628770)
32. JJ Smee JA Epps K Ooms SE Bolte T Polenova B Baruah L Yang W Ding M Li, et al. 2009 Chloro-substituted dipicolinate vanadium complexes: synthesis, solution, solid-state, and insulin-enhancing properties J Inorg Biochem 103 575 10.1016/j.jinorgbio.2008.12.015 10.1016/j.jinorgbio.2008.12.015 1:CAS:528:DC%2BD1MXjsFans7o%3D 19201030
33. AK Srivastava MZ Mehdi 2004 Insulino-mimetic and anti-diabetic effects of vanadium compounds Diabet Med 22 2 13 10.1111/j.1464-5491.2004.01381.x 10.1111/j.1464-5491.2004.01381.x
34. BKH Tan CH Tan PN Pushparaj 2005 Anti-diabetic activity of the semi-purified fractions of Averrhoa bilimbi in high fat diet fed-streptozotocin-induced diabetic rats Life Sci 76 2827 2839 10.1016/j.lfs.2004.10.051 10.1016/j.lfs.2004.10.051 1:CAS:528: DC%2BD2MXivVejurw%3D 15808883 (Pubitemid 40460328)
35. KH Thompson C Orvig 2001 Coordination chemistry of vanadium in metallopharmaceutical candidate compounds Coord Chem Rev 219-221 1033 1053 10.1016/S0010-8545(01)00395-2 10.1016/S0010-8545(01)00395-2 (Pubitemid 32927477)
36. KH Thompson C Orvig 2006 Vanadium in diabetes: 100 years from Phase 0 to Phase I J Inorg Biochem 100 1925 1935 10.1016/j.jinorgbio.2006.08.016 10.1016/j.jinorgbio.2006.08.016 1:CAS:528:DC%2BD28Xht1Cgs7rN 17055061 (Pubitemid 44738038)
37. Tracey AS, Willsky GR, Takeuchi ES (2007) Vanadium chemistry biochemistry, pharmacology and practical applications, 1st edn. CRC Press, Boca Raton
38. D Wei M Li W Ding 2007 Effect of vanadate on gene expression of the insulin signaling pathway in skeletal muscle of streptozotocin-induced diabetic rats J Biol Inorg Chem 12 1265 1273 10.1007/s00775-007-0294-y 10.1007/s00775-007-0294-y 1:CAS:528:DC%2BD2sXhtFKrsbzP 17874149 (Pubitemid 47594266)
39. GR Willsky LH Chi Y Liang DP Gaile Z Hu DC Crans 2006 Diabetes-altered gene expression in rat skeletal muscle corrected by oral administration of vanadyl sulfate Physiol Genomics 26 192 201 10.1152/physiolgenomics.00196.2005 10.1152/physiolgenomics.00196.2005 1:CAS:528:DC%2BD28XhtVGlurrF 16684804 (Pubitemid 44246625)
40. H Yasui A Tamura T Takino H Sakurai 2002 Structure-dependent metallokinetics of antidiabetic vanadyl-picolinate complexes in rats: studies on solution structure, insulinomimetic activity, and metallokinetics J Inorg Biochem 91 327 10.1016/S0162-0134(02)00443-9 10.1016/S0162-0134(02)00443-9 1:CAS:528:DC%2BD38Xlt12msbg%3D 12121792 (Pubitemid 34727782)
41. VG Yuen C Orvig JH McNeill 1993 Glucose-lowering effects of a new organic vanadium complex, bis(maltolato)oxovanadium(IV) Can J Physiol Pharmacol 71 263 269 1:CAS:528:DyaK3sXltlWgsr4%3D 8402390
42. VG Yuen E Vera ML Battell W Li JH McNeill 1999 Acute and chronic oral administration of bis(maltolato)oxovanadium(IV) in Zucker diabetic fatty(ZDF) rats Diabetes Res Clin Pract 43 9 19 10.1016/S0168-8227(98)00120-X 10.1016/S0168-8227(98)00120-X 1:CAS:528:DyaK1MXivVOqsQ%3D%3D 10199584 (Pubitemid 29096407)